Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion

Journal of Endocrinology

Volumn 224, Issue 3, 2015, Pages 205-214

  Lee, Eun Young ^a   Kaneko, Shuji ^b   Jutabha, Promsuk ^c   Zhang, Xilin ^a   Seino, Susumu ^d   Jomori, Takahito ^e   Anzai, Naohiko ^c   Miki, Takashi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

GLP1 secretion; L cell; Miglitol; SGLT3

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; ATROPINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 2; MALTOSE; MIGLITOL; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 3; UNCLASSIFIED DRUG; 1 DEOXYNOJIRIMYCIN; GLYCOSIDASE INHIBITOR; SLC2A2 PROTEIN, MOUSE; SLC5A1 PROTEIN, MOUSE; SLC5A4B PROTEIN, MOUSE; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ABSORPTION; CELL ACTIVATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG POTENCY; DUODENUM; ENTEROENDOCRINE CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VAGUS NERVE; XENOPUS LAEVIS; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

1-DEOXYNOJIRIMYCIN; ACARBOSE; ANIMALS; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TRANSPORTER TYPE 2; GLYCOSIDE HYDROLASE INHIBITORS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SODIUM-GLUCOSE TRANSPORT PROTEINS; SODIUM-GLUCOSE TRANSPORTER 1; XENOPUS LAEVIS;

EID: 84924811717     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0555     Document Type: Article

References (29)

1. Anini Y, Hansotia T&Brubaker PL 2002 Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology 143 2420-2426. (doi:10.1210/endo.143.6.8840)
2. Arakawa M, Ebato C, Mita T, Fujitani Y, Shimizu T, Watada H, Kawamori R & Hirose T 2008 Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. Metabolism 57 1299-1306. (doi:10.1016/j.metabol.2008.04.027)
3. Barcelona S, Menegaz D&Diez-Sampedro A 2012 Mouse SGLT3a generates proton-activated currents but does not transport sugar. American Journal of Physiology. Cell Physiology 302 C1073-C1082. (doi:10.1152/ajpcell.00436.2011)
4. Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW&Lam TK 2012 Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nature Medicine 18 950-955. (doi:10.1038/nm.2745)
5. Breen DM, Rasmussen BA, Cote CD, Jackson VM&Lam TK 2013 Nutrientsensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes 62 3005-3013. (doi:10.2337/db13-0523)
6. Cani PD, Holst JJ, Drucker DJ, Delzenne NM, Thorens B, Burcelin R&Knauf C 2007 GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Molecular and Cellular Endocrinology 276 18-23. (doi:10.1016/j.mce.2007.06.003)
7. Cho YM, Fujita Y&Kieffer TJ 2014 Glucagon-like peptide-1: glucose homeostasis and beyond. Annual Review of Physiology 76 535-559. (doi:10.1146/annurev-physiol-021113-170315)
8. Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM&Koepsell H 2003 A glucose sensor hiding in a family of transporters. PNAS 100 11753-11758. (doi:10.1073/pnas.1733027100)
9. Enc FY, Imeryuz N, Akin L, Turoglu T, Dede F, Haklar G, Tekesin N, Bekiroglu N, Yegen BC, Rehfeld JF et al. 2001 Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. American Journal of Physiology. Gastrointestinal and Liver Physiology 281 G752-G763.
10. Ezcurra M, Reimann F, Gribble FM&Emery E 2013 Molecular mechanisms of incretin hormone secretion. Current Opinion in Pharmacology 13 922-927. (doi:10.1016/j.coph.2013.08.013)
11. Gloster TM&Vocadlo DJ 2012 Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nature Chemical Biology 8 683-694. (doi:10.1038/nchembio.1029)
12. Gorboulev V, Schurmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R et al. 2012 Na(C)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61 187-196. (doi:10.2337/db11-1029)
13. Hiki M, Shimada K, Kiyanagi T, Fukao K, Hirose K, Ohsaka H, Fukushima Y, Kume A, Matsumori R, Sumiyoshi K et al. 2010 Single administration of α-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease. Circulation Journal 74 1471-1478. (doi:10.1253/circj.CJ-10-0013)
14. Mace OJ, Schindler M&Patel S 2012 The regulation of K- and L cell activity by GLUT2 and the calcium-sensing receptor Cas R in rat small intestine. Journal of Physiology 590 2917-2936. (doi:10.1113/jphysiol.2011.223800)
15. Marina AL, Utzschneider KM, Wright LA, Montgomery BK, Marcovina SM & Kahn SE 2012 Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and ß-cell function. Diabetes Care 35 1119-1125. (doi:10.2337/dc11-2050)
16. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R&Grimsby J 2006 The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55 1-12. (doi:10.2337/diabetes.55.01.06.db05-0926)
17. Miki T&Seino S 2005 Roles of KATP channels as metabolic sensors in acute metabolic changes. Journal of Molecular and Cellular Cardiology 38 917-925. (doi:10.1016/j.yjmcc.2004.11.019)
18. Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J&Seino S 1998 Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. PNAS 95 10402-10406. (doi:10.1073/pnas.95.18.10402)
19. Moriya R, Shirakura T, Ito J, Mashiko S&Seo T 2009 Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. American Journal of Physiology. Endocrinology and Metabolism 297 E1358-E1365. (doi:10.1152/ajpendo.00412.2009)
20. Ohlsson L, Kohan AB, Tso P&Ahrén B 2014 GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat. Regulatory Peptides 189 40-45. (doi:10.1016/j.regpep.2014.02.001)
21. Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B et al. 2013 LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. Journal of Pharmacology and Experimental Therapeutics 345 250-259. (doi:10.1124/jpet.113.203364)
22. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ&Gribble FM 2008 Glucose sensing in L cells: a primary cell study. Cell Metabolism 8 532-539. (doi:10.1016/j.cmet.2008.11.002)
23. Sakurai K, Lee EY, Morita A, Kimura S, Kawamura H, Kasamatsu A, Shiiba M, Yabe D, Yokote K&Miki T 2012 Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener. Journal of Diabetes Investigation 3 156-163. (doi:10.1111/j.2040-1124.2011.00163.x)
24. Samulitis BK, Goda T, Lee SM&Koldovsky O 1987 Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine. Drugs Under Experimental and Clinical Research 13 517-524.
25. Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W&Nauck MA 1998 Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to α-glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabetic Medicine 15 485-491. (doi:10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y)
26. Thorens B 2003 A gene knockout approach in mice to identify glucose sensors controlling glucose homeostasis. Pflügers Archiv 445 482-490.
27. Tolhurst G, Reimann F&Gribble FM 2009 Nutritional regulation of glucagon-like peptide-1 secretion. Journal of Physiology 587 27-32. (doi:10.1113/jphysiol.2008.164012)
28. Vincent KM, Sharp JW&Raybould HE 2011 Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut-brain axis in awake rats. Neurogastroenterology and Motility 23 e282-e293. (doi:10.1111/j.1365-2982.2011.01673.x)
29. Voss AA, Diez-Sampedro A, Hirayama BA, Loo DD&Wright EM 2007 Imino sugars are potent agonists of the human glucose sensor SGLT3. Molecular Pharmacology 71 628-634. (doi:10.1124/mol.106.030288)